Putting the record straight on aprotinin as safe and effective: Results from a mixed treatment meta-analysis of trials of aprotinin

Journal of Thoracic and Cardiovascular Surgery

Volumn 145, Issue 1, 2013, Pages 234-240

  Howell, Neil ^a   Senanayake, Eshan ^a   Freemantle, Nick ^b   Pagano, Domenico ^a  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; APROTININ; PLACEBO; TRANEXAMIC ACID;

ARTICLE; BLEEDING; CONFIDENCE INTERVAL; DRUG EFFICACY; DRUG SAFETY; HEALTH CARE PLANNING; HEART SURGERY; HUMAN; META ANALYSIS; MORTALITY; OPERATING ROOM; PEROPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK;

ANTIFIBRINOLYTIC AGENTS; APROTININ; BLOOD LOSS, SURGICAL; EVIDENCE-BASED MEDICINE; HOSPITAL MORTALITY; HUMANS; ODDS RATIO; PATIENT SAFETY; POSTOPERATIVE HEMORRHAGE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REOPERATION; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 84871238644     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2012.07.018     Document Type: Article

References (21)

1. B. Bridgewater, and B. Keogh Sixth National Adult Cardiac Surgical Database report, demonstrating quality 2009 Dendrite Clinical Systems Henley-on-Thames, UK
2. A. Vivacqua, C.G. Koch, A.M. Yousuf, E.R. Nowicki, P.L. Houghtaling, and E.H. Blackstone Morbidity of bleeding after cardiac surgery: is it blood transfusion, reoperation for bleeding, or both? Ann Thorac Surg 91 2011 1780 1790
3. S. Karthik, A.D. Grayson, E.E. McCarron, D.M. Pullan, and M.J. Desmond Reexploration for bleeding after coronary artery bypass surgery: risk factors, outcomes, and the effect of time delay Ann Thorac Surg 78 2004 527 534 discussion 34 (Pubitemid 38980767)
4. B.H. Scott, F.C. Seifert, and R. Grimson Blood transfusion is associated with increased resource utilisation, morbidity and mortality in cardiac surgery Ann Card Anaesth 11 2008 15 19
5. M. Kuduvalli, A.Y. Oo, N. Newall, A.D. Grayson, M. Jackson, and M.J. Desmond Effect of peri-operative red blood cell transfusion on 30-day and 1-year mortality following coronary artery bypass surgery Eur J Cardiothorac Surg 27 2005 592 598 (Pubitemid 40409729)
6. NHS Blood and Transplant Annual review: saving and improving lives 2009/2010 National Health Service Blood Transfusion Review Board Walford, UK
7. D.A. Henry, P.A. Carless, A.J. Moxey, D. O'Connell, B.J. Stokes, and D.A. Fergusson Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion Cochrane Database Syst Rev 3 2011 CD001886
8. D.A. Fergusson, P.C. Hébert, C.D. Mazer, S. Fremes, C. MacAdams, and J.M. Murkin A comparison of aprotinin and lysine analogues in high-risk cardiac surgery N Engl J Med 358 2008 2319 2331 (Pubitemid 351749156)
9. European Medicines Agency [Internet]. London: The Agency; c1995-c2012 [updated 2012 Feb 17; cited 2012 May 2]. European Medicines Agency recommends lifting suspension of aprotinin. Available from: http://www.ema.europa.eu/ema/ index.jsp?curl=pages/news-and-events/news/2012/02/news-detail-001447. jsp&mid=WC0b01ac058004d5c1&jsenabled=true.
10. G. Lu, and A.E. Ades Combination of direct and indirect evidence in mixed treatment comparisons Stat Med 23 2004 3105 3124 (Pubitemid 39334902)
11. M. Levi, M.E. Cromheecke, E. de Jonge, M.H. Prins, B.J. de Mol, and E. Briët Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints Lancet 354 1999 1940 1947
12. D.A. Henry, A.J. Moxey, P.A. Carless, D. O'Connell, B. McClelland, and K.M. Henderson Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion Cochrane Database Syst Rev 1 2001 CD001886
13. A. Sedrakyan, T. Treasure, and J.A. Elefteriades Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials J Thorac Cardiovasc Surg 128 2004 442 448 (Pubitemid 39194703)
14. M. Rosén The aprotinin saga and the risks of conducting meta-analyses on small randomised controlled trials - a critique of a Cochrane review BMC Health Serv Res 9 2009 34
15. C. Young, and R. Horton Putting clinical trials into context Lancet 366 2005 107 108 (Pubitemid 40991198)
16. Health Canada [Internet]. Ottawa: Health Canada; c2012 [updated 2011 Sep 21; cited 2011 Oct 10]. Health Canada decision on Trasylol (aprotinin). Available from: http://www.hc-sc.gc.ca/ahc-asc/media/advisories-avis/-2011/2011- 124-eng.php.
17. S. Schneeweiss, J.D. Seeger, J. Landon, and A.M. Walker Aprotinin during coronary-artery bypass grafting and risk of death N Engl J Med 358 2008 771 783 (Pubitemid 351284455)
18. D. Pagano, N.J. Howell, N. Freemantle, D. Cunningham, R.S. Bonser, and T.R. Graham Bleeding in cardiac surgery: the use of aprotinin does not affect survival J Thorac Cardiovasc Surg 135 2008 495 502 (Pubitemid 351329358)
19. J.J. Gagne, D.E. Griesdale, and S. Schneeweiss Aprotinin and the risk of death and renal dysfunction in patients undergoing cardiac surgery: a meta-analysis of epidemiologic studies Pharmacoepidemiol Drug Saf 18 2009 259 268
20. T.S. Hall, G.R. Brevetti, A.J. Skoultchi, J.C. Sines, P. Gregory, and A.J. Spotnitz Re-exploration for hemorrhage following open heart surgery differentiation on the causes of bleeding and the impact on patient outcomes Ann Thorac Cardiovasc Surg 7 2001 352 357
21. S.M. DeSantis, J.M. Toole, J.M. Kratz, W.E. Uber, M.J. Wheat, and M.R. Stroud Early postoperative outcomes and blood product utilization in adult cardiac surgery: the post-aprotinin era Circulation 124 11 Suppl 2011 S62 S69